Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
- Xeljanz
Descriptions
Tofacitinib is used alone or together with other medicines (eg, DMARDs) to treat moderate to severely active rheumatoid arthritis, active psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, and polyarticular course juvenile idiopathic arthritis (pcJIA) in patients who have taken other medicines (eg, methotrexate) that did not work well.
Tofacitinib is a Janus kinase (JAK) inhibitor that works on the immune system.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
- Tablet
- Tablet, Extended Release
- Solution
Portions of this document last updated: April 01, 2022
Copyright © 2022 IBM Watson Health. Todos los derechos reservados. La información es para uso exclusivo del usuario final y no puede venderse, redistribuirse ni utilizarse de ninguna otra forma con fines comerciales.